Form 4 Filing for Jain Rita at Avalo Therapeutics, Inc.

This filing details a stock option grant to Jain Rita, a director at Avalo Therapeutics, Inc. The option, for 20,100 shares of common stock, was granted on June 2, 2026, with a purchase price of $13.96 per share. The option vests fully on the first anniversary of the grant date, contingent upon continued service. The transaction is reported on Form 4, with the signature dated June 4, 2026. This event does not involve the disposal of any securities, but rather the acquisition of the right to purchase stock at a predetermined price.